Zolbetuximab, also known as IMAB362, is a chimeric mouse-human monoclonal antibody associated with targeting claudin 18 isoform 2, commonly known as CLDN18.2.
CLDN18.2 is a tight-junction-associated protein and pharmaceutical target studied in gastric and gastroesophageal junction oncology research.
Zolbetuximab binds to CLDN18.2-expressing cells and is associated with antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).
It is relevant to targeted oncology pharmaceutical development, gastric cancer research, gastroesophageal junction cancer research, monoclonal antibody development, tumor antigen studies, and biological drug substance research.
Zolbetuximab is associated with CLDN18.2-targeted pharmaceutical research, oncology drug development, monoclonal antibody research, gastric cancer studies, gastroesophageal junction cancer research, and biopharmaceutical development.
CLDN18.2-targeted therapy research
Claudin 18.2 research
Anti-CLDN18.2 monoclonal antibody research
CLDN18.2-directed antibody research
Monoclonal antibody pharmaceutical development
Targeted oncology pharmaceutical research
Cancer immunotherapy research
Gastric cancer pharmaceutical research
Gastric adenocarcinoma research
Gastroesophageal junction cancer research
GEJ adenocarcinoma research
HER2-negative gastric cancer research
Tumor antigen research
Tumor cell surface target research
Tight junction protein research
Claudin protein research
Antibody-dependent cellular cytotoxicity research
ADCC mechanism studies
Complement-dependent cytotoxicity research
CDC mechanism studies
Tumor immunology research
Tumor microenvironment studies
Antineoplastic biological research
Biopharmaceutical development
Biological drug substance research
Biotechnology research and development
Clinical research support
Analytical method development
Biological stability studies
Quality control laboratories
Reference material applications
Pharmaceutical R&D
Contract research support
Research and development applications
Zolbetuximab is also relevant to pharmaceutical and biotechnology organizations involved in CLDN18.2-targeted oncology and monoclonal antibody research.
Research applications may include:
CLDN18.2 binding studies
Claudin 18.2 target research
Antibody-target interaction studies
Monoclonal antibody characterization
Antibody purity analysis
Protein characterization research
Binding affinity studies
Biological potency studies
ADCC assay development
CDC assay development
Cell-based assay development
Tumor antigen expression research
Gastric cancer biomarker research
Biopharmaceutical analytical development
Chromatographic method development
Mass spectrometry research
Biological stability studies
Reference material studies
Quality control method development
Pharmaceutical research applications
Trusted API & Pharmaceutical Raw Material Supplier
Quality-Focused Biological Pharmaceutical Materials
COA & Technical Documentation Support
Customer-Specific Specifications
Reliable Global Supply Chain
Research Quantity Support
Customized Biological Material Packaging
Temperature-Controlled Supply Support
Export Documentation Assistance
Customer Verification Support
Professional Technical Support
Worldwide Supply Assistance
Swapnroop Drugs & Pharmaceuticals supports Zolbetuximab API and biological material enquiries from:
Biopharmaceutical Manufacturers
Monoclonal Antibody Research Companies
Oncology Pharmaceutical Companies
Targeted Therapy Research Companies
Gastric Cancer Research Organizations
Immuno-Oncology Companies
Biotechnology Companies
Biological Drug Development Companies
Research Organizations
Contract Research Organizations (CROs)
Contract Development & Manufacturing Organizations (CDMOs)
Pharmaceutical R&D Centers
Universities & Research Institutes
Analytical Laboratories
Biological Material Traders & Exporters
International Pharmaceutical Buyers
Located in Chhatrapati Sambhajinagar (Aurangabad), Maharashtra, India, we support domestic and international pharmaceutical material enquiries with efficient logistics and export documentation assistance.
We support Zolbetuximab API and biological pharmaceutical material enquiries from biopharmaceutical companies, oncology research organizations, biotechnology companies, monoclonal antibody research organizations, CLDN18.2 research organizations, pharmaceutical R&D centers, analytical laboratories, and qualified international pharmaceutical buyers.
Our team assists customers with:
Product Specifications
Certificate of Analysis (COA)
Technical Documentation
Biological Material Specifications
Packaging Options
Research Quantity Enquiries
Commercial Quotations
Export Documentation
Temperature-Controlled Shipping Support
Customer-Specific Requirements
Supply enquiries are subject to product availability, customer verification, intended end-use, intellectual property considerations, destination-country requirements, and applicable pharmaceutical and biological material regulations.
Zolbetuximab is a specialized monoclonal antibody and biological pharmaceutical drug substance associated with regulated pharmaceutical applications.
Supply enquiries may require customer verification, intended end-use information, regulatory documentation, destination-country details, and intellectual property review.
Pharmaceutical development, clinical research, importation, exportation, and commercial use must comply with applicable national and international regulatory requirements.
Get Bulk Quote via WhatsApp